Join
Live feed
·
INSIDERFilingvia Quantisnow
Indaptus Therapeutics Inc. logo

SEC Form 4: Meckler Jeffrey A bought $24,771 worth of shares (9,692 units at $2.56), increasing direct ownership by 21% to 55,066 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INDP (Indaptus Therapeutics Inc.) and more on Quantisnow.